Neptune (NEPT) on Watch with Amarin (AMRN) Halted
Tweet Send to a Friend
Up)
Traders are chatting up Neptune Technologies & Bioresources, Inc. (Nasdaq: NEPT) related to the pending FDA approval of Amarin's (Nasdaq: AMRN) AMR101.
AMRN is now halted, with news pending. The decision is expected shortly and most on the Street expected approval. NCE determination is another issue that could be come in August.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
AMRN is now halted, with news pending. The decision is expected shortly and most on the Street expected approval. NCE determination is another issue that could be come in August.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.P. Morgan (JPM) CEO Dimon Might Have Enough Votes to Stay Chairman - NY Times
- Apple (AAPL) Turns Positive
- UPDATE: GameStop (GME) Slides Into Close
Create E-mail Alert Related Categories
Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
